Probation granted in Joplin mother's drug possession case

Jeff Lehr, The Joplin Globe, Mo.
·1 min read

Mar. 2—A Joplin mother arrested a year ago on drug and child endangerment charges was assessed probation Monday at her sentencing hearing in Jasper County Circuit Court.

Judge Dean Dankelson suspended imposition of sentence on Kacey L. Myers, 31, on a felony conviction for possession of methamphetamine and placed her on supervised probation for five years.

Myers had pleaded guilty to the charge Jan. 11 in a plea agreement dismissing a related felony count of child endangerment and allowing the suspended imposition of sentence.

The case pertained to charges filed after Joplin police served a search warrant on Jan. 28, 2020, at the defendant's home on New Hampshire Avenue and located a bag containing meth inside a backpack left in a bedroom where her two children slept, according to a probable-cause affdiavit.

Numerous syringes and needles also were discovered in the bedroom, including an uncapped syringe and needle beneath her infant's crib, according to the affidavit.

Jeff Lehr is a reporter for The Joplin Globe.

Recommended Stories

  • Any Other Tired Cooks Need Some Serious Lunch Inspiration?

    My boxed cracker habit just isn't cutting it anymore.

  • Will Hawaii Pass A Psilocybin Legalization Bill? Senator Chang Makes A Strong Case

    Last month, a group of Hawaiian legislators introduced a bill that would legalize and regulate psilocybin, the active compounds in “magic mushrooms.” “The reason I wanted to introduce this measure is because, as you know, in the 2020 election, a number of jurisdictions across the country, including Oregon, Oakland, Sacramento, Denver, Somerville, have moved forward with different legislation on psilocybin and further research and application of its mental health properties. And I believe that Hawaii should be part of that movement,” said Hawaii Senator Stanley Chang, one of the bill’s proponents. Last November, Oregon became the first state to legalize and launch a program for the therapeutic use of psilocybin. A number of other jurisdictions are currently looking into developing similar programs. Chang introduced his bill, SB738, with Sens. Laura Acasio, Les Ihara, Jr. and Maile Shimabukuro. The goal is to remove psilocybin and psilocin from the list of Schedule I substances and require Hawaii’s Department of Health to establish treatment centers for the therapeutic administration of these compounds. Will The Bill Pass? The bill could have a significant effect on the Hawaiian population when it comes to providing access to alternative mental health treatments. However, according to Chang, the bill is not a sure victory yet. There are over three thousand bills introduced every year in Hawaii’s legislature. Only less than 10% make it through both houses and get signed into law. “The odds are that it is relatively not likely,” said the senator. “A big part of the legislative process is not just actually passing a bill, but taking part in a community discussion about what the issues are, what the priorities should be." Psilocybin may not be at the point today where there's a community wide-consensus of its therapeutic value, he explained. “That's our job as legislators and policymakers, to engage in that conversation, to determine what is valuable, what's not valuable," Chang said. "And, you know, that's an ongoing conversation that we need to have.” A Growing Emphasis On Mental Health For Chang and his colleagues, the psilocybin bill is part of a larger process to improve mental health treatment across the state. Chang sees mental health as one of his legislative priorities. “I think that there's a growing emphasis on mental health,” said Chang. He observes a growing belief that mental health should be treated in the same way as physical health and given the same level of priority. Despite decades of activism, mental health continues to be placed behind physical health when it comes to policy-making priorities. Earlier this year, Chang introduced a bill that requires insurers to offer annual mental health check-ups in addition to physical health check-ups. Psilocybin could also be a key element in a shift towards achieving a balance between mental and physical health coverage. “At the policymaking level, we're finally catching up to a process that's been going on for years in the medical community. And we're finally starting to understand that the research shows that there are significant benefits to this type of treatment and that, at the very least, we should be conducting a lot more of this research.” Benzinga Photo See more from BenzingaClick here for options trades from BenzingaPsyched: Inside A Psilocybin Retreat, CA Bill Would Decriminalize Psychedelics, Revive Buys Psilocybin IPColumbia Care CEO, Ayr Wellness COO Talk Up NJ's New Recreational Cannabis Market© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

  • Dr. Seuss Canceled By Virginia School System For ‘Read Across America’ Day

    In Virginia, they do not like green eggs and ham, or Dr. Seuss. The good Dr. Seuss, aka Theodor Geisel, has been dropped from the annual ‘Read Across America’ event, a national day to encourage reading. Dr. Seuss books have long been a staple of the program. Dr. Seuss, a major supplier of content for […]

  • The Golden Globes completely ignored I May Destroy You – and made it more powerful than ever

    In spite of fierce competition from the muted microphones, the awkward camera cuts, Daniel Kaluuya’s refusal to be interrupted mid-acceptance speech, and Jason Sudeikis’ tie-dye hoodie, the real winner of last night’s Golden Globes was a woman who wasn’t there. When the 2021 nominations were announced last month, the internet had an instant meltdown over the exclusion of I May Destroy You, the BBC-HBO drama series written, show-run by, and starring Michaela Coel, which tackled sexual consent, drugs and drinking culture, life as black millennial Londoner specifically, and the ethical perplexities of being a human being more generally. Despite topping pretty much every list of the best TV shows of the year, the shadowy cabal of voters at the Hollywood Foreign Press Association – which Gary Oldman once described as “90 nobodies having a w---k” – clearly found Coel’s show a bit meh. Or perhaps they just didn’t get round to watching it. Either way, its absence from the TV categories led to the Globes itself being labelled everything from an evil abomination to a very bad joke, and the HFPA coming under increased scrutiny for its less-than-diverse make-up and shady nomination practices. Which is a pretty powerful outcome for a show that walked away empty handed. Indeed, despite its obvious injustice, I May Destroy You’s snubbing by what is generally agreed to be the trashiest and least meritocratic prize-giving, in an awards season populated exclusively by trashy and unmeritocratic prize-givings, has only redoubled its fame and increased its prestige. It wasn’t just that the actors and creatives who were nominated had to endure an evening of technological hiccups and mild humiliations – although it isn’t hard to imagine Coel chuckling through her popcorn as the camera cut to a frozen-smiled Lily Collins when host Tina Fey quipped that “French Exit is what I did after watching the first episode of Emily in Paris”, or at Viola Davis’s undisguised expression of utter boredom throughout. Certainly, this year’s Globes is unlikely to go down in history as a show that encouraged us to take anyone in attendance more seriously.

  • Insecticide known for killing pollinators found in deer across Minnesota

    Powerful insecticides are turning up in deer in nearly every corner of Minnesota, raising concerns that the ubiquitous chemicals may be keeping fawns from surviving to maturity or harming deer reproduction. Neonicotinoids, known for their devastating effects on pollinator populations across the continent, are typically applied to row crops and household lawns. But the Minnesota Department of ...

  • Harry and Meghan Begged to Delay Oprah Broadcast While Prince Philip Is Gravely Ill

    DANIEL LEAL-OLIVAS / Getty ImagesPrince Harry and Meghan Markle are being urged by some commentators in the U.K. to ask CBS to postpone the airing of its Oprah Winfrey interview, in which they are expected to mount a stinging attack on the royal family, as concern mounts over Prince Philip’s prospects of beating an infection.Prince Harry Tells Oprah He Left the Royals Because He Feared Meghan Markle Would Suffer Like Princess Diana Philip, 99, was moved to a specialist heart hospital on Monday and royal sources have been quoted by British newspapers saying the family is “pretty appalled” at the idea of the interview, which Oprah has said sees Meghan saying “pretty shocking things” being broadcast while Philip is so unwell.Penny Junor, author of Prince Harry, Brother, Soldier, Son, told The Daily Beast that airing the interview while Prince Philip was undergoing very public health travails risked making the interview look inappropriate, saying: “Anything could hijack this interview. Philip is ill. He is 99 and could die at any time. They were not to know he would get ill, but it could be seen to be the wrong time. But I doubt it is in their gift to postpone the interview. The control is in the hands of CBS and Oprah.”Robert Lacey, historical consultant for The Crown and author of the definitive royal biography Majesty, told The Daily Beast: “I think it would be a marvelous turnaround for Harry’s image if he took the brave step of canceling the whole thing this weekend—or, if that’s not practical, postponing it at least.”Royal commentator and former editor of Who’s Who Richard Fitzwilliams said it would “surely be appropriate” to postpone the interview.He told MailOnline: “Oprah is their friend and neighbor and would undoubtedly comply if asked and the gesture would I am sure be appreciated by the royal family. If an interview has been extended, as this recently has, it can also be postponed, as this undoubtedly should be.” Royal biographer Robert Jobson told the Mail: “With the Duke of Edinburgh clearly very unwell, the fact that the couple plan to go ahead with airing their self-indulgent, no-holds-barred interview with chat show queen Oprah Winfrey makes them appear heartless, thoughtless, and supremely selfish.“For U.S. broadcast network CBS, this interview is a coup, all about securing big viewing figures and big advert sales around the airing of their exclusive interview. So even if they wanted to Harry and Meghan probably couldn’t dictate terms to Oprah Winfrey and the network now. Too much has been invested.”A TV industry insider told the Mirror: “CBS has sold millions of dollars worth of advertising around the interview, but bosses are aware of the delicacy of the Duke’s heath. They have no loyalty to the royal family, although some feel as though they do to Harry and Meghan. For it to run if Philip’s condition worsened would be like setting off a diplomatic bomb. It would be grossly insensitive and hugely disrespectful.”Read more at The Daily Beast.Get our top stories in your inbox every day. Sign up now!Daily Beast Membership: Beast Inside goes deeper on the stories that matter to you. Learn more.

  • U.S. Supreme Court mulls power of landmark law in major voting rights case

    U.S. Supreme Court justices on Tuesday will consider whether to uphold two Republican-backed voting restrictions in Arizona in a case that could further weaken the Voting Rights Act, a landmark 1965 federal law that barred racial discrimination in voting. The important voting rights case comes before the justices at a time when Republicans in numerous states are pursuing new restrictions after former President Donald Trump made false claims of widespread fraud in the Nov. 3 election that he lost to Democratic President Joe Biden.

  • There Are 6 Treatments Helping Patients Survive COVID-19

    Carl Court/GettyBy William G. Bain, Georgios D. Kitsios, and Tomeka L. SuberA year ago, when U.S. health authorities issued their first warning that COVID-19 would cause severe “disruption to everyday life,” doctors had no effective treatments to offer beyond supportive care.There is still no cure, but thanks to an unprecedented global research effort, several treatments are helping patients survive COVID-19 and stay out of the hospital altogether.COVID-19 treatments target two broad problems: the coronavirus’s ability to spread through the body, and the damage caused by the body’s immune system response. When the virus enters the body, it takes over cells and uses them to replicate itself. In response, the body sends inflammatory signals and immune cells to fight the virus. In some patients, that inflammatory response can continue even after the virus is under control, leading to damage in the lungs and other organs.The best tool is prevention, including using face masks and vaccines. Vaccines train the immune system to fight off attackers. With less risk of an uncontrolled infection, they can cut the risk of death from COVID-19 to near zero. But vaccine supplies are limited, even with a third vaccine now authorized for U.S. use, so treatments for infected patients remain crucial.This Drug Is a Staple of COVID Treatment. Should It Be?As doctors who work with COVID-19 patients, we have been following the drug trials and success stories. Here are six treatments commonly used today for COVID-19. As you’ll see, timing matters.Keeping you out of the hospitalTwo promising types of treatments involve injecting antiviral antibodies into high-risk COVID-19 patients before the person becomes severely ill.Our bodies naturally create antibodies to recognize foreign invaders and help fight them off. But natural antibody production takes several days, and SARS-CoV-2—the coronavirus that causes COVID-19—replicates fast. Studies show that injecting patients with antibodies soon after symptoms begin can help protect patients against serious infection.Monoclonal antibodies: These lab-engineered antibodies can bind to SARS-CoV-2 and prevent the virus from entering cells and infecting them. They include Bamlanivimab and the combined therapy casirivimab/imdevimab developed by Regeneron. The U.S. Food and Drug Administration granted emergency use authorization for these therapies because they have been found to protect high-risk patients from hospitalization and death. Once patients are sick enough to need hospitalization, however, studies haven’t found a proven benefit from them.Convalescent plasma: Another way to deliver antibodies involves blood drawn from patients who have recovered from COVID-19. Convalescent plasma is primarily given in research settings because the clinical evidence so far is mixed. Some trials show benefits early in the disease. Other studies have not shown any benefit in hospitalized patients.There may be a role for convalescent plasma as a supplemental therapy for some patients because of the growing threat of mutated SARS-CoV-2 variants, which may evade monoclonal antibody therapy. However, careful research is necessary.If you are hospitalizedOnce patients become so sick that they have to be hospitalized, treatments change.Most hospitalized patients have difficulty breathing and low oxygen levels. Low oxygen occurs when the virus and corresponding immune response injure the lungs, resulting in swelling in lung air sacs that restricts the amount of oxygen getting into the blood. Patients hospitalized with COVID-19 usually need supplemental medical oxygen to help them breathe. Doctors frequently treat patients on oxygen with the antiviral agent remdesivir and anti-inflammatory corticosteroids.Remdesivir: Remdesivir, originally designed to treat hepatitis C, stops the coronavirus from replicating itself by interfering with its genetic building blocks. It has been shown to shorten the length of hospital stays, and doctors may prescribe it to patients on oxygen shortly after arrival in the hospital.Chris Christie Says He’s Out of the Hospital After Week-Long Stay for COVID-19Corticosteroids: Steroids calm the body’s immune response and have been used for decades to treat inflammatory disorders. They are also widely available, cheap and well-studied medications, so they were among the first therapies to enter clinical trials for COVID-19. Several studies have shown that low-dose steroids reduce deaths in hospitalized patients who are on oxygen, including the sickest patients in the intensive care unit, or ICU. Following the findings of the landmark RECOVERY and REMAP-CAP COVID-19 studies, steroids are now the standard of care for patients hospitalized with COVID-19 who are treated with oxygen.Blood thinners: Inflammation during COVID-19 and other viral infections can also increase the risk of blood clots, which can cause heart attacks, strokes and dangerous clots in the lungs. Many patients with COVID-19 are given the blood thinners heparin or enoxaparin to prevent clots before they occur. Early data from a large trial of COVID-19 patients suggests that hospitalized patients benefit from higher doses of blood thinners.Some patients with COVID-19 become so sick that they need an ICU for high levels of oxygen support or a ventilator to help them breathe. There are several therapies available for ICU patients, but ICU patients have not been found to benefit from high doses of blood thinners.Treating the sickest patientsICU patients with COVID-19 are more likely to survive if they receive steroids, studies have found. However, low-dose steroids alone may not be enough to curb excessive inflammation.Tocilizumab: Tocilizumab is a lab-generated antibody that blocks the interleukin-6 pathway, which can cause inflammation during COVID-19 and other diseases. New results from the REMAP-CAP trial that have not yet been peer-reviewed suggest that a single dose of tocilizumab given within one to two days after being placed on respiratory support reduced the risk of death in patients already receiving low-dose steroids. Tocilizumab has also been shown to benefit patients with high levels of inflammation in early results from another trial.These innovative therapies can help, but careful supportive care in the ICU is also crucial. Decades of extensive research have defined core management principles for helping patients with severe lung infections who need ventilators. These include avoiding underinflation and overinflation of the lung by the ventilator, treating pain and anxiety with low levels of sedative medications, and periodically placing certain patients with low oxygen levels on their belly, among many other interventions. The same key principles likely apply to patients with COVID-19 to help them survive and recover from a critical illness that can last weeks or months.Medical progress since the start of the pandemic has been awe-inspiring. Doctors now have vaccines, antiviral antibodies for high-risk outpatients and several treatments for hospitalized patients. Continued research will be crucial to improve our ability to fight a disease that has already claimed more than 2.5 million lives worldwide.William G. Bain, Georgios D. Kitsios, and Tomeka L. Suber are assistant professors of medicine at the University of PittsburghRead more at The Daily Beast.Get our top stories in your inbox every day. Sign up now!Daily Beast Membership: Beast Inside goes deeper on the stories that matter to you. Learn more.

  • Republican goes on Fox to complain about ‘big media’ not reporting Cuomo story broken by NYT

    New York governor Andrew Cuomo is facing calls to resign over allegations of sexual misconduct

  • Covid-19 variants pose 'real threat' to vaccine progress, CDC warns

    A top health expert says highly contagious variants of the virus pose a "real threat" to the US.

  • Hutchinson gets 6th shutout, Maple Leafs beat Oilers 3-0

    Michael Hutchinson stopped 31 shots for his sixth career shutout, and the Toronto Maple Leafs beat the Edmonton Oilers 3-0 on Monday night. Morgan Rielly and William Nylander each had a goal and an assist, and Zach Hyman also scored for Toronto. The Maple Leafs blanked Edmonton for the second straight game, following a 4-0 win Saturday.

  • Giuliani suspended from YouTube over election conspiracies again, days after returning to platform

    Giuliani is facing a $2.7 billion lawsuit from a voting technology company for spreading election conspiracies

  • Boeing's first fighter-like jet completes historic test flight

    Boeing and the Royal Australian Air Force (RAAF) announced Tuesday local time that they've completed the first test flight of a pilotless fighter-like jet devised to operate alongside crewed aircraft.Why it matters: The "Loyal Wingman" combat drone is serving as the foundation for the Boeing Airpower Teaming System being developed for the company's global defense customers. It has the potential to "revolutionize the RAAF's air combat tactics playbook," per The Drive.Get market news worthy of your time with Axios Markets. Subscribe for free.#LoyalWingman has flown into the history books! Together with @AusAirForce, we’ve completed the first test flight for this smart, human-machine team aircraft. pic.twitter.com/oV5qz6AJIu— The Boeing Company (@Boeing) March 2, 2021 The big picture: A Boeing test pilot was monitoring from a ground control station in South Australia's outback during the autonomous plane's flight, according to a joint statement from Boeing and the RAAF.The Australian government has invested US$31 million in the product, which Boeing said previously has drawn interest from countries including the U.S., Reuters notes. It's the first military plane designed and made in Australia in over 50 years.What they're saying: Air Vice-Marshal Cath Roberts, RAAF Head of Air Force Capability, said in a statement, "The Loyal Wingman project is a pathfinder for the integration of autonomous systems and artificial intelligence to create smart human-machine teams."Flashback: Boeing's pilotless vehicle flies for first timeLike this article? Get more from Axios and subscribe to Axios Markets for free.

  • Boeing to base U.S. Air Force prototype on Australian pilotless combat jet

    Boeing Co will use a pilotless, fighter-like jet developed in Australia as the basis for its U.S. Air Force Skyborg prototype, an executive at the plane maker said on Tuesday. The "Loyal Wingman", the first military aircraft to be designed and manufactured in Australia in more than 50 years, made its first flight on Saturday under the supervision of a Boeing test pilot monitoring it from a ground control station in South Australia. Boeing's Loyal Wingman is 38 feet long (11.6 metres), has a 2,000 nautical mile (3,704 km) range and a nose that can be outfitted with various payloads.

  • Mitt Romney knocked unconscious and needed stitches after weekend fall

    The Utah senator was visiting his grandchildren over the weekend when he fell

  • Can new Angels pitcher Alex Cobb recapture the form Joe Maddon saw in Tampa Bay?

    Despite Alex Cobb's recent struggles, he still reminds Angels manager Joe Maddon of the pitcher who had a 3.21 ERA from 2011 to 2014 with the Rays.

  • The Supreme Court Will Hear a Case That Could Weaken What's Left of the Voting Rights Act

    The U.S. Supreme Court is seen in Washington, DC, on January 31, 2017. The U.S. Supreme Court will hear oral arguments on Tuesday on two controversial Arizona voting restrictions, and what the justices decide could have sweeping effects on how difficult it will be to challenge allegedly discriminatory voting laws in the future. The cases being argued together on March 2 concern two voting policies in Arizona, a key battleground state in the 2020 election: one banning ballot collection—the process by which someone collects and drops off others’ mail-in ballots—and one requiring officials to throw out ballots cast at wrong precincts.

  • Two accused of helping Ghosn escape land in Japan

    Two Americans accused of helping former Nissan Chairman Carlos Ghosn flee Japan arrived in Tokyo on Tuesday (March 2).U.S. Special Forces veteran Michael Taylor and his son, Peter Taylor, were extradited by U.S. authorities.The pair could face days of questioning over their role in the elaborate escape plan.Prosecutors say the Taylors, who were private security specialists, received $1.3 million for their services.It's expected they will face charges after an investigation is concluded.The Taylors have been in U.S. custody since their arrest in May.And are accused of helping Ghosn flee Japan in 2019.The former car exec was awaiting trial on charges that he had engaged in financial wrongdoing at Nissan. Including accusations he enriched himself through payments to car dealerships. Ghosn denies wrongdoing. The Taylors' lawyers had argued that they face the prospect of relentless interrogations and torture.But the U.S. Supreme Court last month cleared the way for the extradition.U.S. officials declined to comment, as did the Tokyo District Public Prosecutors Office, which is handling the case.The Taylors are alleged to have helped Ghosn flee Japan hidden in a box on a private jet.The ousted auto industry heavyweight fled to his childhood home Lebanon, which has no extradition treaty with Japan.

  • An eagle-eyed 'Harry Potter' fan noticed leads being replaced by random actors in a 'Prisoner of Azkaban' scene

    A viral TikTok pointed out an error with characters like Harry Potter, Hermione Granger, and Ron Weasley during a scene in the third movie.

  • Nurse: I'm correcting COVID conspiracy theories inside and outside the health care industry

    Misinformation runs rampant online, even from my colleagues in the health care industry. We need to do better.